Related by context. Frequent words. (Click for all words.) 74 chronic myeloid leukemia CML 72 chronic myelogenous leukemia CML 66 relapsed refractory 65 Ph + CML 65 chronic myeloid leukemia 65 chronic lymphocytic leukemia CLL 65 gastrointestinal stromal tumors 64 myeloid 63 Ph + ALL 62 T#I mutation 62 systemic lupus erythematosus SLE 62 Traficet EN 61 indolent NHL 61 metastatic renal cell carcinoma 61 rheumatoid factor 61 cutaneous T cell 61 myeloproliferative disorders 61 aHUS 61 EGFR inhibitors 61 glioblastoma multiforme GBM 61 luteinizing hormone releasing 60 T2DM 60 hypoxia inducible factor 60 non alcoholic steatohepatitis 60 superficial bladder cancer 60 mTOR inhibitor 60 Acute Myeloid Leukemia AML 60 angiogenesis inhibitor 60 chronic myelogenous leukemia 60 nilotinib 60 myelodysplastic syndrome MDS 60 acute myelogenous leukemia AML 60 hemolytic anemia 60 cytogenetic response 60 heavily pretreated 60 Ofatumumab 60 systemic lupus erythematosus 60 dasatinib 60 Azedra 60 acute myeloid leukemia AML 59 peripheral blood mononuclear 59 pheochromocytoma 59 complete cytogenetic 59 PsA 59 Chronic Lymphocytic Leukemia 59 imatinib mesylate 59 HER2 positive metastatic breast 59 lupus nephritis 59 romidepsin 59 lymphoma CTCL 59 pertuzumab 59 hepatitis C HCV 59 idiopathic pulmonary fibrosis IPF 59 B CLL 58 Pegasys ® 58 myelofibrosis 58 organ transplant rejection 58 Carfilzomib 58 relapsed refractory multiple myeloma 58 Imatinib 58 AA amyloidosis 58 Zolinza 58 mRCC 58 Amrubicin 58 Irinotecan 58 LY# [003] 58 orally bioavailable 58 Combination therapy 58 tyrosine kinase inhibitor 58 FLT3 57 HGS ETR1 57 paroxysmal nocturnal hemoglobinuria PNH 57 BRAF mutation 57 ifosfamide 57 Voreloxin 57 Bortezomib 57 chlorambucil 57 hematological cancers 57 daunorubicin 57 elotuzumab 57 Sym# 57 Phase 2a clinical 57 tumor lysis syndrome 57 medullary thyroid cancer 57 bleomycin 57 relapsed multiple myeloma 57 biologic therapy 57 Natalizumab 57 ALN TTR# 57 Metastatic Melanoma 57 acute lymphoblastic leukemia 57 breast carcinoma 57 chronic plaque psoriasis 57 ponatinib 57 IV melanoma 57 lymphopenia 57 beta thalassemia 57 administered subcutaneously 57 purpura 56 IMC A# 56 humanized antibody